| 000 | 01597 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513105540.0 | ||
| 264 | 0 | _c19970102 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/s002620050310 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXie, K | |
| 245 | 0 | 0 |
_aBcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cOct 1996 |
||
| 300 |
_a109-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3T3 Cells _xcytology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCytokines _xphysiology |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 |
_aPenicillamine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xbiosynthesis |
| 650 | 0 | 4 | _aS-Nitroso-N-Acetylpenicillamine |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aHuang, S | |
| 700 | 1 | _aWang, Y | |
| 700 | 1 | _aBeltran, P J | |
| 700 | 1 | _aJuang, S H | |
| 700 | 1 | _aDong, Z | |
| 700 | 1 | _aReed, J C | |
| 700 | 1 | _aMcDonnell, T J | |
| 700 | 1 | _aMcConkey, D J | |
| 700 | 1 | _aFidler, I J | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 43 _gno. 2 _gp. 109-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002620050310 _zAvailable from publisher's website |
| 999 |
_c8946212 _d8946212 |
||